As per this study the Global Biotech Ingredients Market was valued USD XX MN (by revenue) in 2019 and is anticipated to reach USD XX MN by 2026 with a CAGR of XX%.
Biotech ingredients are complex chemical mixtures these are largely bioactive and originally found in biological sources such as botanical, animal or microbial. Biotech ingredients are produced using complex biotechnological processes such as genetic engineering, hybridoma technology, and others. Biotech ingredients categorized into innovative biotech APIs and generic biotech APIs also known as biosimilars.
The increasing geriatric population and the growing prevalence of chronic diseases such as cancer and other is driving the market growth. In addition, shifting preference of consumers towards organic and natural products is again boosting the market growth. However, high initial cost and GMO hesitation may restrict the market growth in the forecast timeframe. Whereas, technological advancements associated with monoclonal antibodies (mAbs) and next-generation antibody therapies such as antibody-drug conjugates are expected to be a promising growth opportunity to the market.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of biotech ingredients.
The broad biotech ingredients market has been sub-grouped into type, product and expression system. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
- Innovative Biotech APIs
By Expression System
- Monoclonal Antibodies
- Hormones And Growth Factors
- Fusion Proteins
- Therapeutic Enzymes
- Blood Factors
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for biotech ingredients in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Biotech Ingredients Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the biotech ingredients market include Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Glaxosmithkline, Merck, Novartis International, Pfizer, Sanofi and Teva Pharmaceutical Industries. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.